SGRY VS PRGO Stock Comparison

PerformanceAnalyst Price TargetsTechnicalsEarningsProfitVolatilityDividend
PerformanceAnalyst Price TargetsTechnicalsEarningsProfitVolatilityDividend

Performance

SGRY
10/100

SGRY returned 4.97% in the last 12 months. Based on SPY's performance of 13.09%, its performance is below average giving it a score of 10 of 100.

PRGO
61/100

PRGO returned -11.57% in the last 12 months. Based on SPY's performance of -13.03%, its performance is above average giving it a score of 61 of 100.

Analyst Price Targets

SGRY
61/100

9 analysts offer 12-month price targets for SGRY. Together, they have an average target of 64, the most optimistic target put SGRY at 64 within 12-months and the most pessimistic has SGRY at 64.

PRGO
60/100

18 analysts offer 12-month price targets for PRGO. Together, they have an average target of 51, the most optimistic target put PRGO at 54 within 12-months and the most pessimistic has PRGO at 48.

Technicals

SGRY
64/100

SGRY receives a 64 of 100 based on 14 indicators. 8 are bullish, 4 are bearish.

PRGO
43/100

PRGO receives a 42 of 100 based on 14 indicators. 5 are bullish, 7 are bearish.

Earnings

SGRY
10/100

SGRY has missed earnings 11 times in the last 20 quarters.

PRGO
10/100

PRGO has missed earnings 9 times in the last 20 quarters.

Profit

SGRY
61/100

Out of the last 20 quarters, SGRY has had 14 profitable quarters and has increased their profits year over year on 7 of them.

PRGO
43/100

Out of the last 20 quarters, PRGO has had 10 profitable quarters and has increased their profits year over year on 5 of them.

Volatility

SGRY
47/100

SGRY has had a lower than average amount of volatility over the last 12 months giving it a score of 47 of 100.

PRGO
46/100

PRGO has had a lower than average amount of volatility over the last 12 months giving it a score of 46 of 100.

Dividend

SGRY

"Dividend" not found for SGRY

PRGO
64/100

PRGO's most recent dividend was $0.19 per share, based on a share price of $28.89. It was a payout ratio of 32.19% compared to their total earnings.

All score calculations are broken down here to help you make more informed investing decisions

Surgery Partners, Inc. Common Stock Summary

Nasdaq / SGRY
Healthcare
Medical - Care Facilities
Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through two segments, Surgical Facility Services and Ancillary Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care; and ancillary services, which consist of multi-specialty physician practices, urgent care facilities, and anesthesia services. As of December 31, 2021, it owned or operated a portfolio of 126 surgical facilities, including 108 ambulatory surgical centers and 18 surgical hospitals in 31 states. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.

PERRIGO COMPANY PLC Summary

New York Stock Exchange / PRGO
Healthcare
Drug Manufacturers - Specialty & Generic
Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through two segments, Consumer Self-Care Americas and Consumer Self-Care International. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America. The segment offers its products under the Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh, and Burt's Bees brand names. The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 23 countries, primarily in Europe. The company also offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.